121 related articles for article (PubMed ID: 74193)
21. Prognosis of threatened abortion. A comparative study with the use of vaginal cytology and urinary gonadotropin immunoassay.
Youssef AF; Naguib YA; Fayad MM; Hussein M
Am J Obstet Gynecol; 1971 Jan; 109(1):8-11. PubMed ID: 5538976
[No Abstract] [Full Text] [Related]
22. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
[TBL] [Abstract][Full Text] [Related]
23. [Studies on the significance of the quantitative immunologic pregnancy tests for the diagnosis of endangered pregnancy and abortus imminens].
Dapunt O; Loewit K
Arch Gynakol; 1967; 204(2):116-7. PubMed ID: 5631113
[No Abstract] [Full Text] [Related]
24. Maternal serum alpha-fetoprotein levels in anembryonic pregnancy.
Stabile I; Olajide F; Chard T; Grudzinskas JG
Hum Reprod; 1989 Feb; 4(2):204-5. PubMed ID: 2465308
[TBL] [Abstract][Full Text] [Related]
25. [Alpha-fetoprotein in assessing obstetric diagnosis (author's transl)].
Anger H; Merz E; Gleissenberger H; Dittmar FW
Z Geburtshilfe Perinatol; 1975 Aug; 179(4):286-91. PubMed ID: 52234
[TBL] [Abstract][Full Text] [Related]
26. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
Karsidag AY; Buyukbayrak EE; Kars B; Suyugul U; Unal O; Turan MC
J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
[TBL] [Abstract][Full Text] [Related]
27. [Changes in the blood level of alpha-fetoprotein in threatened abortion].
Berlingieri D; Borrelli AL; Caserta R; Maisto G; Iannucci F; De Falco D
Arch Ostet Ginecol; 1982; 87(1-2):21-32. PubMed ID: 6193773
[No Abstract] [Full Text] [Related]
28. Bioactive to immunoreactive ratio of circulating human chorionic gonadotropin as possible evaluation for the prognosis of threatened abortion.
Camejo MI; Proverbio F; Febres F; Casart YC
Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):181-4. PubMed ID: 12860338
[TBL] [Abstract][Full Text] [Related]
29. [Chorionic gonadotropin excretion in threatened abortion, incomplete abortion and ectopic pregnancy].
Hepp H
Geburtshilfe Frauenheilkd; 1967 Oct; 27(10):990-9. PubMed ID: 5598836
[No Abstract] [Full Text] [Related]
30. Labor induction versus expectant management at early term in pregnancies with second trimester elevated human chorionic gonadotropin or alpha fetoprotein.
Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
J Obstet Gynaecol Res; 2018 Jun; 44(6):1049-1056. PubMed ID: 29516643
[TBL] [Abstract][Full Text] [Related]
31. [Studies on a new quantitative immunological pregnancy test].
Loewit K
Wien Klin Wochenschr; 1967 Apr; 79(14):251-6. PubMed ID: 5589965
[No Abstract] [Full Text] [Related]
32. The use of human chorionic gonadotropin levels in assessing the prognosis of threatened abortion.
Grob PR; Gibbs FJ
Practitioner; 1972 Jul; 209(249):79-81. PubMed ID: 5041755
[No Abstract] [Full Text] [Related]
33. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
34. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
35. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
36. Early pregnancy failure: study by ultrasonic and hormonal methods.
Jouppila P; Huhtaniemi I; Tapanainen J
Obstet Gynecol; 1980 Jan; 55(1):42-7. PubMed ID: 7352061
[TBL] [Abstract][Full Text] [Related]
37. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
38. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
Thong KJ; Norman JE; Baird DT
Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the prognosis of threatened abortion by the determination of HCG in serum and urine].
Reiertsen O; Sande HA; Fønstelien E; Torjesen P
Tidsskr Nor Laegeforen; 1980 Dec; 100(34-36):2038-40. PubMed ID: 7456066
[No Abstract] [Full Text] [Related]
40. Taking account of vaginal bleeding in screening for Down's syndrome.
Cuckle H; van Oudgaarden ED; Mason G; Holding S
Br J Obstet Gynaecol; 1994 Nov; 101(11):948-53. PubMed ID: 7528053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
